Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
There are various ways to earn fast with a strategic plan. Explore these methods to increase your income effectively.
23,345 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Institutional hands move in the ETF space as second line capital buys into a short-maturity strategy. This article br...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
CrowdStrike stock just 52-week highs signal strong momentum, but investors must weigh the run-up against real growth....
NVIDIA unveiled a bold plan to embed AI chips in nearly every PC, signaling a turning point for the way computers are...
A major shift in early trading set the tone for Accenture's latest results. This article explains why accenture stock...
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
Sandisk stock dropped again as memory-chip demand uncertainty echoed through the market. This guide breaks down why t...
A major fund manager disclosed a sizable sale of Invesco KBW Bank ETF shares, trimming exposure to U.S. banks. This a...
Gates Capital Management just raised its TIC Solutions position even as TIC’s stock fell this year. Learn what this m...
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...